Home LiteratureArticle Details
PMID: 22397654 Published · ppublish English Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Immunologic correlates of the abscopal effect in a patient with melanoma.

The New England journal of medicine ·Vol. 366 ·No. 10 ·2012-03-08 ·Pages 925-31

Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, Mu Z, Rasalan T, Adamow M, Ritter E, Sedrak C, Jungbluth AA, Chua R, Yang AS, Roman RA, Rosner S, Benson B, Allison JP, Lesokhin AM, Gnjatic S, Wolchok JD

Abstract

The abscopal effect is a phenomenon in which local radiotherapy is associated with the regression of metastatic cancer at a distance from the irradiated site. The abscopal effect may be mediated by activation of the immune system. Ipilimumab is a monoclonal antibody that inhibits an immunologic checkpoint on T cells, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). We report a case of the abscopal effect in a patient with melanoma treated with ipilimumab and radiotherapy. Temporal associations were noted: tumor shrinkage with antibody responses to the cancer-testis antigen NY-ESO-1, changes in peripheral-blood immune cells, and increases in antibody responses to other antigens after radiotherapy. (Funded by the National Institutes of Health and others.).

MeSH Terms
Adult Antibodies/blood Antibodies, Monoclonal/therapeutic use Combined Modality Therapy Female Humans Ipilimumab Lung Neoplasms/drug therapy,immunology,radiotherapy,secondary Melanoma/drug therapy,immunology,radiotherapy,secondary Neoplasm Metastasis/immunology Skin Neoplasms/pathology
Chemicals
Antibodies Antibodies, Monoclonal Ipilimumab
Authors & Affiliations
21 authors, click to expand affiliations / ORCID
Postow Michael A
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Callahan Margaret K
Barker Christopher A
Yamada Yoshiya
Yuan Jianda
Kitano Shigehisa
Mu Zhenyu
Rasalan Teresa
Adamow Matthew
Ritter Erika
Sedrak Christine
Jungbluth Achim A
Chua Ramon
Yang Arvin S
Roman Ruth-Ann
Rosner Samuel
Benson Brenna
Allison James P
Lesokhin Alexander M
Gnjatic Sacha
Wolchok Jedd D
References (23)
23 references, click to expand
  1. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer.
    Cancer Res. 1999 Dec 15;59(24):6028-32 PMID: 10626784
  2. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
    J Exp Med. 2007 Jan 22;204(1):49-55 PMID: 17210731
  3. Improved survival with ipilimumab in patients with metastatic melanoma.
    N Engl J Med. 2010 Aug 19;363(8):711-23 PMID: 20525992
  4. Whole body irradiation; radiobiology or medicine?
    Br J Radiol. 1953 May;26(305):234-41 PMID: 13042090
  5. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.
    Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34 PMID: 15701862
  6. Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.
    Cancer Res. 2012 Feb 15;72(4):876-86 PMID: 22174368
  7. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
    Clin Cancer Res. 2009 Dec 1;15(23):7412-20 PMID: 19934295
  8. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.
    Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):862-70 PMID: 14967443
  9. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
    Int J Cancer. 1999 Nov 12;83(4):456-64 PMID: 10508479
  10. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
    Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16723-8 PMID: 21933959
  11. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
    N Engl J Med. 2011 Jun 30;364(26):2517-26 PMID: 21639810
  12. Autoantibodies against cancer antigens.
    Methods Mol Biol. 2009;520:11-9 PMID: 19381944
  13. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma.
    Oncogene. 2002 Jun 6;21(25):3969-77 PMID: 12037679
  14. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
    J Immunol Methods. 2009 Feb 28;341(1-2):50-8 PMID: 19041653
  15. Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.
    Clin Cancer Res. 2010 May 15;16(10):2861-71 PMID: 20460488
  16. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.
    Int J Cancer. 2001 Jun 15;92(6):856-60 PMID: 11351307
  17. The immunobiology of cancer immunosurveillance and immunoediting.
    Immunity. 2004 Aug;21(2):137-48 PMID: 15308095
  18. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.
    Clin Cancer Res. 2009 Sep 1;15(17):5379-88 PMID: 19706802
  19. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.
    J Clin Oncol. 2007 Jun 20;25(18):2546-53 PMID: 17577033
  20. Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.
    Int J Cancer. 1999 Oct 22;84(5):506-10 PMID: 10502728
  21. The abscopal effect: demonstration in lymphomatous involvement of kidneys.
    Med Pediatr Oncol. 1981;9(5):473-6 PMID: 7029238
  22. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
    Acta Oncol. 2006;45(4):493-7 PMID: 16760190
  23. An interesting case of possible abscopal effect in malignant melanoma.
    Br J Radiol. 1975 Oct;48(574):863-6 PMID: 811297
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2012-03-08
Pages
925-31
Language
English
Region
United States
NLM ID
0255562
PMCID
PMC3345206
Subset
IM
Grants
NCI NIH HHS · RC2CA148468 · United States
NCI NIH HHS · R25 CA020449 · United States
NCI NIH HHS · RC2 CA148468 · United States
Howard Hughes Medical Institute · United States
NCI NIH HHS · P30 CA008748 · United States
NCI NIH HHS · R01 CA056821 · United States
NCI NIH HHS · RC2 CA148468-02 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]